compounding pharmacy and semaglutide for weight loss | Blog Exploring the Ozempic Shortage: Unique

Healthcare (and related) news highlights from this week Brandon Aylward, Research Consultant What's an article that caught your eye in the last week

Infusion of GLP-1 into healthy humans and diabetics by several groups established the role of GLP-1 as an incretin and a potential therapeutic for diabetes

Maximum: 14 mg once daily, if 7 mg dose is insufficient Possible side effects include: Gastrointestinal: nausea, vomiting, diarrhea The long-term safety of GLP-1 receptor agonists has not yet been established

As a result, it is estimated that 29% to 44% of adults with PWS may suffer from bone fractures due to the higher prevalence of osteoporosis, reported to be as high as 21% (78)

The clinical data backs up the excitement